Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 205040
Company: CIPLA LIMITED
Company: CIPLA LIMITED
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| RITONAVIR | RITONAVIR | 25MG | TABLET; ORAL | None (Tentative Approval) | None | TBD | No |
| RITONAVIR | RITONAVIR | 50MG | TABLET; ORAL | None (Tentative Approval) | None | No | No |
Original Approvals or Tentative Approvals
| Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
|---|---|---|---|---|---|---|---|
| 03/29/2015 | ORIG-1 | Tentative Approval | Type 5 - New Formulation or New Manufacturer | PRIORITY |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/205040Orig1s000TAltr.pdf |